Reply to 'Comment on "Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.
Bowyer, S Prithviraj, P Larkin, J McArthur, G Atkinson, V Millward, M Khou, M Diem, S Ramanujam, S
Bowyer, S
Prithviraj, P
Larkin, J
McArthur, G
Atkinson, V
Millward, M
Khou, M
Diem, S
Ramanujam, S
Citations
Altmetric:
Abstract
Description
Date
2017-04-11
Publisher
Collections
Keywords
Type
Article
Citation
Reply to 'Comment on "Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''. 2017, 116(8):e15 Br J Cancer